Researchers at the Eugene and Marilyn Glick Eye Institute and the Indiana Center for Vascular Biology and Medicine led by Rajashekhar Gangaraju, PhD, are working toward the clinical trials stage for stem cell treatments that are designed to stop and possibly reverse diabetic retinopathy related vision loss.
More Articles on Ophthalmology:
Flaum Eye Institute Recruits Dr. Harold Ross
$3.6M in Series A Funding Goes to MacuLogix
MCRHS Eye Care Welcomes Dr. Elizabeth Garland
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
